Vesilion Tablets (Befotastine Besilate)

Adult dose

Usually, the adult dosage is 10mg of bepotastine besilate orally twice daily. The dosage may be adjusted according to the patient's age and symptoms.

This medication should not be used in patients with hypersensitivity to its ingredients. Caution should be exercised when administering it to patients with renal or liver impairment, and to elderly individuals. While taking this medication, symptoms such as drowsiness, headache, dizziness, as well as gastrointestinal symptoms like vomiting and diarrhea may occur. Additionally, changes in blood counts or liver function tests may occur, and allergic reactions such as skin rashes or swelling may also develop. When taking this medication, care should be taken to avoid accidents while driving or operating hazardous machinery due to drowsiness. Patients who have been on long-term steroid therapy should gradually reduce their steroid dosage when starting this medication. Patients with renal impairment may have increased blood concentration of this medication; therefore, treatment should begin with a lower dosage, and dosage adjustments or discontinuation may be necessary if adverse symptoms occur. For patients with seasonal allergic rhinitis, it is advisable to start taking this medication before the predictable allergy season and continue until the season is over. If no effects are seen, long-term use is not recommended. Concurrent use with other antihistamines or alcohol should be avoided. Pregnant women or those who may become pregnant should refrain from taking this medication unless absolutely necessary and should consult a physician. Breastfeeding women are also advised to avoid taking this medication during lactation. Safety in children has not been established; thus, caution is needed when administering it to them. Elderly individuals may have decreased renal function, which may raise the risk of increased blood concentration; therefore, caution is necessary. This medication may affect the results of allergy testing; therefore, it is advised not to take it before such tests. Medication should be taken as directed, and care should be taken not to swallow the packaging. Keep this medication out of reach of children, and store it in a cool, dry place below 30 degrees Celsius.

• Drowsiness
• lethargy
• headache
• heaviness
• dizziness
• dry mouth
• xerostomia
• glossitis
• nausea
• vomiting

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Maintain a storage temperature between 1 and 30 degrees Celsius to preserve its effectiveness and safety.

Appearance

White film-coated tablets with a dividing line

Package unit

60 tablets (10 tablets/PTP X 6), 300 tablets/bottle, 30 tablets/bottle